3.1 Contrast Media Types, Properties & Special Considerations

Why Contrast Media Knowledge Is Tested So Heavily

Contrast media and medication content is one dense subcategory ("Patient Care 1.B") inside the ARRT Content Specifications for Computed Tomography, and it carries all 9 numbered outline items under Patient Interactions and Management. Because roughly 43% of Procedures questions also layer a "Contrast Media" focus theme (indications, scan/prep delay, effect on images) on top of anatomy-specific questions, a technologist who is shaky on contrast media types, osmolality, and special-population considerations loses points across the exam, not just in the Patient Care category. This section covers the foundational agents and the patient-specific factors that determine whether — and how — contrast is given.

Contrast Media Types and Properties

CT uses two broad contrast strategies: positive contrast (increases attenuation, appears bright/white) and negative or neutral contrast (decreases or does not add attenuation, appears dark or unenhanced).

• Iodinated (water-soluble) contrast — the workhorse IV agent for essentially every enhanced CT study. Nearly all modern formulations are nonionic, meaning the molecule does not dissociate into charged particles in solution. This matters because dissociation drives osmolality (particles in solution per kilogram of water), and higher osmolality is directly linked to a higher rate of adverse reactions.
• Barium sulfate — an enteric (GI-tract) positive contrast agent used for bowel opacification. It is contraindicated when bowel perforation or anastomotic leak is suspected, because free barium in the peritoneal cavity causes a severe chemical peritonitis; dilute water-soluble iodinated oral contrast is substituted in that scenario.
• Air / carbon dioxide — negative-contrast agents used to distend the colon for CT colonography, taking advantage of the natural attenuation difference between gas and soft tissue.
• Water — a neutral oral agent (roughly 0 HU) used in CT enterography and some urographic protocols specifically because it does not obscure post-contrast bowel wall enhancement the way a dense positive agent would.

Osmolality Classes

Most departments stock a nonionic LOCM at an iodine concentration of 300–370 mgI/mL — that concentration number, multiplied by injected volume, is exactly what dose-calculation questions test (see Section 3.2).

Special Contrast Considerations

The ARRT outline names five special-consideration buckets, and each is a favorite source of scenario questions:

• Contraindications — the classic example is a documented iodinated contrast allergy (a prior moderate/severe reaction), which triggers either a premedication protocol or an alternate imaging plan. Uncontrolled hyperthyroidism is also a relative contraindication, since iodine load can precipitate thyroid storm.
• Indications — contrast is added whenever the clinical question depends on vascular enhancement, organ perfusion, or lesion-enhancement pattern (e.g., differentiating a cyst from a solid enhancing mass).
• Pregnancy — iodinated contrast crosses the placenta. Current guidance is a risk-benefit decision: use it only if the result will change management and the study cannot be deferred; theoretical fetal thyroid suppression risk from modern LOCM/IOCM is considered low.
• Lactation — this is a frequently misremembered rule. Less than 1% of an injected iodinated (or gadolinium) dose enters breast milk, and less than 1% of that small amount is absorbed by the infant's gut. Current ACR/ACOG guidance is that breastfeeding can continue on its normal schedule without any interruption — the older "24-hour pump-and-dump" advice is outdated and is not required.
• Dialysis patients — iodinated contrast is not an emergency indication for unscheduled dialysis. For a patient already on a hemodialysis schedule, contrast is cleared at the next routine session; coordination of timing (rather than urgent dialysis) is the correct action.

Noncontrast Medications the Technologist Must Recognize

The outline also calls out four noncontrast medications a CT technologist should be able to identify in a patient's chart or protocol order:

• Lidocaine — local anesthetic, used before line placement or a CT-guided biopsy.
• Nitroglycerin — a vasodilator sometimes given before cardiac or vascular CT to improve luminal visualization.
• Metoprolol — a beta-blocker given before coronary CT angiography to slow heart rate (commonly targeting under 60–65 bpm) for motion-free coronary imaging.
• tPA (tissue plasminogen activator) — a thrombolytic; recognizing it in a patient's recent history (e.g., post-stroke treatment) is relevant to timing and bleeding-risk considerations around the CT visit.

Exam Scenario

A technologist receives an order for a contrast-enhanced abdominal CT on a patient who is currently breastfeeding twins. The patient asks whether she needs to "pump and dump" for 24 hours. The correct, current answer is no — she may continue nursing on her normal schedule immediately after the scan, because the amount of iodinated contrast that reaches breast milk and is then absorbed by an infant is negligible.

Key Takeaways

• Nearly all modern IV iodinated CT contrast is nonionic, in either the LOCM (~600–850 mOsm/kg) or IOCM (~290 mOsm/kg) class; ionic HOCM is essentially retired for IV use.
• Barium sulfate is contraindicated with suspected perforation/leak — substitute a water-soluble iodinated oral agent.
• Current guidance permits breastfeeding to continue without interruption after iodinated or gadolinium contrast — do not default to the outdated 24-hour pump-and-dump rule.
• Dialysis patients can receive iodinated contrast; coordinate with the existing hemodialysis schedule rather than triggering an unscheduled dialysis session.
• Know lidocaine, nitroglycerin, metoprolol, and tPA by function — the exam expects recognition, not just definitions.